接受替西帕单抗治疗时多发性骨髓瘤所致复发性心脏压塞

Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab.

作者信息

Hurtado Alexander, Luebbe Samuel T, Kilbane Emma, Awoyemi Toluwalase, Bronson Taylor, Mehta Jayesh, Al-Kazaz Mohamed M H, Lin Adam Y

机构信息

McGaw Medical Center of Northwestern University, Chicago, Illinois, USA.

Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

出版信息

JACC Case Rep. 2024 Dec 4;29(23):102763. doi: 10.1016/j.jaccas.2024.102763.

DOI:10.1016/j.jaccas.2024.102763

PMID:39691339

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11646921/

Abstract

Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.

摘要

双特异性疗法改变了多发性骨髓瘤的治疗模式。我们报告了一名患者，在治疗期间出现复发性恶性心包积液并伴有心脏压塞以及新发心房颤动，这表明新发或恶化的心包疾病可能是双特异性疗法的一种潜在心血管不良反应。